Literature DB >> 15951476

Hemodynamic effects of acute administration of atomoxetine and methylphenidate.

Ronan P Kelly1, Kwee Poo Yeo, Choo-Hua Teng, Brian P Smith, Stephen Lowe, Danny Soon, Holly A Read, Stephen D Wise.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15951476     DOI： 10.1177/0091270005276737

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  9 in total

1.  Atomoxetine for amphetamine-type stimulant dependence during buprenorphine treatment: A randomized controlled trial.

Authors:  Richard S Schottenfeld; Marek C Chawarski; Mehmet Sofuoglu; Weng-Tink Chooi; Norzarina M Zaharim; M Azhar M Yasin; Imran Ahmad; Sharifah Zubaidiah Syed Jaapar; B Kasinather Vicknasingam
Journal:  Drug Alcohol Depend       Date:  2018-03-10       Impact factor: 4.492

Review 2.  Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder.

Authors:  Gary Stiefel; Frank M C Besag
Journal:  Drug Saf       Date:  2010-10-01       Impact factor: 5.606

Review 3.  Switching from neurostimulant therapy to atomoxetine in children and adolescents with attention-deficit hyperactivity disorder : clinical approaches and review of current available evidence.

Authors:  Suyash Prasad; Chris Steer
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

Review 4.  Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management.

Authors:  Johnny Graham; David Coghill
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

5.  Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis.

Authors:  Hao-Jie Zhu; Kennerly S Patrick; Hong-Jie Yuan; Jun-Sheng Wang; Jennifer L Donovan; C Lindsay DeVane; Robert Malcolm; Julie A Johnson; Geri L Youngblood; Douglas H Sweet; Taimour Y Langaee; John S Markowitz
Journal:  Am J Hum Genet       Date:  2008-05-15       Impact factor: 11.025

Review 6.  A systematic review of combination therapy with stimulants and atomoxetine for attention-deficit/hyperactivity disorder, including patient characteristics, treatment strategies, effectiveness, and tolerability.

Authors:  Tamás Treuer; Susan Shur-Fen Gau; Luis Méndez; William Montgomery; Julie A Monk; Murat Altin; Shenghu Wu; Chaucer C H Lin; Héctor J Dueñas
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-04-06       Impact factor: 2.576

7.  Effects of norepinephrine reuptake inhibition on postural tachycardia syndrome.

Authors:  Elizabeth A Green; Vidya Raj; Cyndya A Shibao; Italo Biaggioni; Bonnie K Black; William D Dupont; David Robertson; Satish R Raj
Journal:  J Am Heart Assoc       Date:  2013-09-03       Impact factor: 5.501

8.  The Effect of Methylphenidate and Atomoxetine on Heart Rate and Systolic Blood Pressure in Young People and Adults with Attention-Deficit Hyperactivity Disorder (ADHD): Systematic Review, Meta-Analysis, and Meta-Regression.

Authors:  Edwin F Liang; Samuel Z Lim; Wilson W Tam; Cyrus S Ho; Melvyn W Zhang; Roger S McIntyre; Roger C Ho
Journal:  Int J Environ Res Public Health       Date:  2018-08-20       Impact factor: 3.390

9.  A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorder.

Authors:  Gabrielle A Carlson; David Dunn; Douglas Kelsey; Dustin Ruff; Susan Ball; Lisa Ahrbecker; Albert J Allen
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2007-09-27       Impact factor: 3.033
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.